Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-22

Clinical Trial Update: Efficacy of Atorvastatin in Chronic Subdural Haematoma [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating atorvastatin for chronic subdural hematoma; efficacy results not yet reported (status unknown).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atorvastatin (atorvastatin)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Chronic Subdural Hematoma | Phase 3 | Status: UNKNOWN